News & Events CTI Announces Anna McBride to Oversee Global Clinical Monitoring Department

CTI Announces Anna McBride to Oversee Global Clinical Monitoring Department

May 27, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ May 27, 2020]

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces the addition of Anna McBride to the CTI team in the role of Vice President, Global Clinical Monitoring.

Anna McBride, BSN, MBA
VP Global Clinical Monitoring
  
Anna comes to CTI with more than 30 years of experience in the pharmaceutical and clinical research industry. Most recently, prior to joining CTI, Anna served as Vice President, Clinical Trial Operations at a mid-size global CRO, where she directed the Clinical Trial Operations North American division of the company and managed cross-global studies. Throughout her career, Anna has also gained experience as a clinical nurse specializing in Neurosurgery and NICU, a CRA, a GCP auditor, and a patient and site recruiter. Anna received a Bachelor’s degree in Psychology and her BSN from Emory University. She also earned an MBA from Golden Gate University. 

In her role as VP Global Clinical Monitoring, Anna will manage and oversee the Clinical Monitoring function at CTI, managing team members working in more than 40 countries around the world. 

“We are thrilled to welcome Anna to CTI’s clinical group,” remarks Kevin Schwarz, Chief Operating Officer. “Her extensive and varied leadership experience in the health and pharmaceutical industry will be a significant asset to the growing team at CTI.”
 
    

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com

Subscribe to our mailing list

* indicates required